A compound of Formula wherein, B is benzotriazolyl, phenyl, triazolopyridinyl, or -(CH 2) 2 triazolyl each of which may be unsubstituted or substituted by 1, 2, or 3 substituents independently chosen from -C 1-3 alkyl, -O-C 1-3 alkyl, CN, -(CH 2) 2 -O-(CH 2) 2 -OR 4 and halo; D is -C OH, -C NHSO 2 CH 3, -SO 2 NHC CH 3, 5-(trifluoromethyl)-4H-1,2,4-triazol-2-yl, or tetrazolyl; R 1 is independently hydrogen, C 1-3 alkyl, F, C 3-6 spirocycloalkyl, oxetane, or the two R 1 groups together with the carbon to which they are attached form a cyclopropyl group; R 2 is hydrogen, methyl, CF 3, or halo; R 4 is hydrogen or -C 1-3 alkyl; Linker is -CH 2 -, -CH 2 -N(-cyclopropyl)-CH 2 -, -CH 2 -N(CH 3)-CH 2 - or -N-(CH 3)-CH 2 -; A is tetrahydrobenzoxazepinyl, tetrahydro-pyrido-oxazepinyl, piperidinyl, tetrahydrobenzazepinyl, phenyl, pyrazolyl, imidazolyl, triazolyl, tetrazolyl, tetrahydropyrrolopyrazinyl, imidazopyridinyl, pyridyl, benzimidazolyl, tetrahydrobenzodiazepinyl, piperidopyrimidinyl, dioxidotetrahydrothiophenyl, tetrahydroimidazodiazepinyl, pyrrolidinyl, oxazepane or morpholinyl; All of which may be unsubstituted or substituted by 1, 2, or 3 substituents independently chosen from -C 1-3 alkyl, C 3-6 spirocycloalkyl, halo, CN, -O-C 1-3 alkyl, -CH 2 -O-CH 3, and OH; And the piperidinyl may additionally be independently substituted by pyrazolyl, - CH 2 pyrazolyl, or oxadiazolyl each of which may be further independently substituted by -C 1-3 alkyl, or, when A is piperidinyl, it may be substituted by -SO 2 R, wherein R is -C 1-3 alkyl, phenyl or C 3-7 cycloalkyl; And the oxazepane may additionally be independently substituted by 1 or 2 of -C 1-3 alkyl or -C 3-7 cycloalkyl; And the morpholinyl may additionally be substituted by a phenyl which itself may be independently substituted by C 1-3 alkyl or -O- C 1-3 alkyl; And the pyrrolidinyl may be additionally substituted by a triazolyl group which itself is may be substituted by -C 1-3 alkyl; And the imidazolyl, triazolyl, pyrazolyl, and tetrazolyl groups may be additionally independently substituted by -CH 2 -C 4-7 cycloalkyl, -CH 2 -C 5-7 heterocycloalkyl, -CH 2 -azabicycloheptanyl, -CH 2 -oxepane, or -CH 2 -azabicyclohexanyl, all of which, including the - CH 2 -, may be further substituted independently by 1 or 2 of -C 1-3 alkyl or F; and X is independently CH or N; or a pharmaceutically acceptable salt thereof. B is benzotriazolyl, phenyl, triazolopyridinyl, or -(CH 2) 2 triazolyl each of which may be unsubstituted or substituted by 1, 2, or 3 substituents independently chosen from -C 1-3 alkyl, -O-C 1-3 alkyl, CN, -(CH 2) 2 -O-(CH 2) 2 -OR 4 and halo; D is -C OH, -C NHSO 2 CH 3, -SO 2 NHC CH 3, 5-(trifluoromethyl)-4H-1,2,4-triazol-2-yl, or tetrazolyl; R 1 is independently hydrogen, C 1-3 alkyl, F, C 3-6 spirocycloalkyl, oxetane, or the two R 1 groups together with the carbon to which they are attached form a cyclopropyl group; R 2 is hydrogen, methyl, CF 3, or halo; R 4 is hydrogen or -C 1-3 alkyl; Linker is -CH 2 -, -CH 2 -N(-cyclopropyl)-CH 2 -, -CH 2 -N(CH 3)-CH 2 - or -N-(CH 3)-CH 2 -; A is tetrahydrobenzoxazepinyl, tetrahydro-pyrido-oxazepinyl, piperidinyl, tetrahydrobenzazepinyl, phenyl, pyrazolyl, imidazolyl, triazolyl, tetrazolyl, tetrahydropyrrolopyrazinyl, imidazopyridinyl, pyridyl, benzimidazolyl, tetrahydrobenzodiazepinyl, piperidopyrimidinyl, dioxidotetrahydrothiophenyl, tetrahydroimidazodiazepinyl, pyrrolidinyl, oxazepane or morpholinyl; All of which may be unsubstituted or substituted by 1, 2, or 3 substituents independently chosen from -C 1-3 alkyl, C 3-6 spirocycloalkyl, halo, CN, -O-C 1-3 alkyl, -CH 2 -O-CH 3, and OH; And the piperidinyl may additionally be independently substituted by pyrazolyl, - CH 2 pyrazolyl, or oxadiazolyl each of which may be further independently substituted by -C 1-3 alkyl, or, when A is piperidinyl, it may be substituted by -SO 2 R, wherein R is -C 1-3 alkyl, phenyl or C 3-7 cycloalkyl; And the oxazepane may additionally be independently substituted by 1 or 2 of -C 1-3 alkyl or -C 3-7 cycloalkyl; And the morpholinyl may additionally be substituted by a phenyl which itself may be independently substituted by C 1-3 alkyl or -O- C 1-3 alkyl; And the pyrrolidinyl may be additionally substituted by a triazolyl group which itself is may be substituted by -C 1-3 alkyl; And the imidazolyl, triazolyl, pyrazolyl, and tetrazolyl groups may be additionally independently substituted by -CH 2 -C 4-7 cycloalkyl, -CH 2 -C 5-7 heterocycloalkyl, -CH 2 -azabicycloheptanyl, -CH 2 -oxepane, or -CH 2 -azabicyclohexanyl, all of which, including the - CH 2 -, may be further substituted independently by 1 or 2 of -C 1-3 alkyl or F; and X is independently CH or N;